Is NCT07076485 recruiting in Voorhees Township, NJ?

Yes, NCT07076485 is currently recruiting participants at its Voorhees Township, NJ location. This breast cancer clinical trial is actively enrolling qualified participants.

How do I join the breast cancer clinical trial in Voorhees Township?

To join this clinical trial in Voorhees Township, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Voorhees Township clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Breast Cancer Clinical Trial in Voorhees Township, NJ

Who Can Participate

Inclusion Criteria

Eligibility Criteria Applicable to All Cohorts Histologically confirmed invasive breast cancer (nodal involvement from presumed invasive breast cancer in the setting of occult breast cancer is sufficient to meet this criteria) 1\. Regional nodal irradiation recommended by treating radiation oncologist. 2 Negative final surgical margins. 3 No more than 12 weeks have elapsed since final breast/lymph node surgery for patients treated with surgery alone or neoadjuvant chemotherapy. No more than 12 weeks have elapsed since final cytotoxic chemotherapy for patients who received adjuvant chemotherapy. 5. Age ≥18 years. Because breast cancer is exceedingly rare in patients \< 18 years of age, children are excluded from this study. 6. Patients with a prior or concurrent malignancy are eligible provided that the natural history and treatment of the prior or concurrent malignancy does not interfere with the safety or efficacy assessment of the investigational radiation regimen used in this trial. 7. Ability to understand and the willingness to sign a written informed consent document. 8. Concurrent enrollment on other observational, translational, or therapeutic studies is allowed provided there is no direct conflict between the other protocol and the radiation regimen proscribed in this trial. Eligibility Criteria for the Low-Risk Lumpectomy Cohort

For patients treated with upfront surgery, pathologic stage pT0-T4b N0-N3a breast cancer without infraclavicular or internal mammary nodal involvement.

For patients treated with neoadjuvant chemotherapy, clinical stage cT0-T4b N0-N2a breast cancer.

Treated with lumpectomy (or axillary surgery only in the case of occult primary breast cancer)

No nodal boost recommended by the treating radiation oncologist. Eligibility Criteria for the High-Risk Lumpectomy Cohort

Treated with neoadjuvant chemotherapy

Clinical stage cT0-T4b N1-N3a/b/c

Treated with lumpectomy (or axillary surgery only in the case of occult primary breast cancer)

Nodal boost recommended by the treating radiation oncologist. Eligibility Criteria for the Low-Risk Mastectomy Cohort

For patients treated with upfront surgery, pathologic stage T0-T2 N0-N2a

For patients treated with neoadjuvant chemotherapy, clinical stage T0-T3 N0- N2a

For patients treated with neoadjuvant chemotherapy, residual cellularity of primary tumor ≤ 20%.

Treated with mastectomy

Negative surgical margins ≥ 2 mm.

No or only focal lymphovascular space invasion.

Age ≥ 40 years

Chest wall boost NOT recommended by treating radiation oncologist. Eligibility Criteria for High-Risk Mastectomy Cohort

For patients treated with upfront surgery, pathologic stage T0-T4d N0-N3c

For patients treated with neoadjuvant chemotherapy, clinical stage T0-T4d N0- N3c

Treated with mastectomy

Chest wall boost and/or nodal boost recommended by treating radiation oncologist Pregnancy Status (applicable to all cohorts) Therapeutic radiation is known to be teratogenic. As a result, women of child-bearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry and for the duration of radiation treatment. (Refer to Pregnancy Assessment Policy MD Anderson Institutional Policy # CLN1114). This includes all female patients, between the onset of menses (as early as 8 years of age) and 55 years unless the patient presents with an applicable

Exclusion Criteria

ary factor which may be one of the following:

Postmenopausal (no menses in greater than or equal to 12 consecutive months).

History of hysterectomy or bilateral salpingo-oophorectomy.

Ovarian failure (Follicle Stimulating Hormone and Estradiol in menopausal range, who have received Whole Pelvic Radiation Therapy).

History of bilateral tubal ligation or another surgical sterilization procedure. Approved methods of birth control are as follows: Hormonal contraception (i.e. birth control pills, injection, implant, transdermal patch, vaginal ring), Intrauterine device (IUD), Tubal Ligation or hysterectomy, Subject/Partner post vasectomy, Implantable or injectable contraceptives, and condoms plus spermicide. Not engaging in sexual activity for the total duration of the radiation therapy course is an acceptable practice; however periodic abstinence, the rhythm method, and the withdrawal method are not acceptable methods of birth control. Should a woman become pregnant or suspect she is pregnant while she or her partner is participating in this study, she should inform her treating physician immediately. Men treated or enrolled on this protocol must also agree to use adequate contraception during the radiation treatment course. Pregnancy testing at the time of study enrollment is not required of women who enroll. However, all patients must comply with the Institutional Pregnancy Assessment Policy (# CLN1114) which requires pregnancy testing within 7 days prior to simulation. Exclusion Criteria: History of therapeutic radiation overlapping with the index breast or nodal basins that require radiation therapy. History of scleroderma Pregnant women are excluded from this study because ionizing radiation has the potential for teratogenic or abortifacient effects. Patients with psychiatric illness/social situations that would limit compliance with study requirements

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Voorhees Township?

Yes, this clinical trial (NCT07076485) has an active research site in Voorhees Township, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Breast Cancer Treatment Options in Voorhees Township, NJ

If you're searching for breast cancer treatment options in Voorhees Township, NJ, this clinical trial (NCT07076485) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Voorhees Township research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all breast cancer clinical trials near you to find additional studies recruiting in your area.

Breast Cancer Clinical Trial in Voorhees Township, NJ

Expert Care in Voorhees Township

IRB Approved

No-Cost Care

Apply for This Voorhees Township Location

Why Participate?

Simple Process

About This Breast Cancer Study in Voorhees Township